Highlights of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Prescott
Lawrence M
LM
D000225:Adenine / Q000031:analogs & derivatives; D023241:Antiretroviral Therapy, Highly Active; D015224:Dideoxynucleosides; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D000068817:Epoetin Alfa; D004921:Erythropoietin; D015658:HIV Infections / Q000188:drug therapy*; D006526:Hepatitis C; D006801:Humans; D019259:Lamivudine; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011994:Recombinant Proteins; D019258:Saquinavir / Q000008:administration & dosage; D000068698:Tenofovir; D015215:Zidovudine; D000099227:Abacavir
D000225:Adenine; D015224:Dideoxynucleosides; D004338:Drug Combinations; D000068817:Epoetin Alfa; D004921:Erythropoietin; D019259:Lamivudine; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011994:Recombinant Proteins; D019258:Saquinavir; D000068698:Tenofovir; D015215:Zidovudine; C418262:abacavir, lamivudine, and zidovudine drug combination; D000099227:Abacavir